Results 181 to 190 of about 138,725 (257)

Multifaceted Intervention by the Hsp90 Inhibitor Ganetespib (STA-9090) in Cancer Cells with Activated JAK/STAT Signaling

, 2011
David A. Proia, Kevin P. Foley, Tim Korbut, Jim Sang, Don Smith, Richard C. Bates, Yuan Liu, Alex Rosenberg, Dan Zhou, Keizo Koya, James Barsoum, Ronald K. Blackman   +11 more
openalex   +2 more sources

Single cell immunoprofile of synovial fluid in rheumatoid arthritis with TNF/JAK inhibitor treatment. [PDF]

Nat Commun
Xia X, He C, Xue Z, Wang Y, Qin Y, Ren Z, Huang Y, Luo H, Chen HN, Zhang WH, Huang LB, Shi Y, Bai Y, Cai B, Wang L, Zhang F, Qian M, Zhang W, Shu Y, Yin G, Xu H, Xie Q.   +21 more
europepmc   +1 more source

Sustained Interferon Signature Suppression With Anifrolumab in a Patient With STING-Associated Vasculopathy with Onset in Infancy Refractory to JAK Inhibitor and Dazukibart Therapy. [PDF]

Arthritis Rheumatol
Alehashemi S, Buehring B, de Jesus AA, Gaurav S, Rastegar A, Baumgardner A, Friend K, Arisa OT, Figg WD, Fink D, Kuhns DB, Colton B, Peer CJ, Goldbach-Mansky R.   +13 more
europepmc   +1 more source

A single-cell RNA-seq dataset of synovial fluid from rheumatoid arthritis treated with TNF-α/JAK inhibitor. [PDF]

Sci Data
He C, Ren Z, Xia X, Xue Z, Zhang F, Qian M, Shu Y, Yin G, Xie Q, Xu H.   +9 more
europepmc   +1 more source

Effects of IL-6, JAK, TNF inhibitors, and CTLA4-Ig on knee symptoms in patients with rheumatoid arthritis [PDF]

Koichi Murata, Ryuji Uozumi, Takayuki Fujii, Akira Onishi, Kosaku Murakami, Hideo Onizawa, Masao Tanaka, Akio Morinobu, Shuichi Matsuda   +8 more
openalex   +1 more source

Epac1 Inhibits Orbital Fibroblast Activation to Ameliorate Thyroid-Associated Orbitopathy-Like Features Through the JAK/STAT Signaling Pathway [PDF]

Rong Liu, Xin Xin, Shunguo Ma, Jin‐Min Guo, Chenmian Wu, Xin Qi, Ban Luo   +6 more
openalex   +1 more source

Severe mixed hand and generalized eczema treated with the JAK inhibitor upadacitinib. [PDF]

J Dtsch Dermatol Ges
Cramer N, Mohr J, Schön MP, Mössner R.
europepmc   +1 more source

Increased Levels of Inflammatory Proteins, Including TARC/CCL17, in Skin of AD Patients During JAK Inhibitor Treatment. [PDF]

Clin Exp Allergy
Boesjes CM, van der Gang LF, Bakker DS, den Hartog Jager CF, de Graaf M, de Bruin-Weller MS, van Wijk F, Knol EF.   +7 more
europepmc   +1 more source

Successful Treatment of Ixekizumab-Induced Paradoxical Eczematous Reaction with JAK Inhibitors: A Case Report

Jingqiu Fu, Jiejie Lu, Weiwei Wu, Ping Wang   +3 more
openalex   +2 more sources

Exploratory study on the efficacy of topical pan-JAK inhibitor in ocular and skin GVHD in a sclerodermatous GVHD mouse model. [PDF]

Sci Rep
Sato S, Ogawa Y, Asai K, Shimizu E, Shimizu S, Taniguchi H, Okazaki T, Shimmura S, Negishi K, Hirayama M.   +9 more
europepmc   +1 more source